HCV and Non-Hepatic Malignancy: Is Pre-Emptive DAA Therapy Indicated Prior to Treatment?

Hepatology - United States
doi 10.1002/hep.29414
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

How Effective and How Durable Is DAA‐therapy in HCV‐infected Drug Users?

Liver International
Hepatology
2019English

Pre-Emptive Versus Non Pre-Emptive Kidney Transplantation for End-Stage Kidney Disease

Cochrane Database of Systematic Reviews
2018English

“Pre-Emptive Strike”-The Case for Early Treatment of Hepatic Sinusoidal Obstruction Syndrome With Defibrotide

Pediatric Blood and Cancer
OncologyChild HealthHematologyPerinatologyMedicinePediatrics
2018English

Low-Protein Vegetarian Diet With Alpha-Chetoanalogues Prior to Pre-Emptive Pancreas-Kidney Transplantation

Review of Diabetic Studies
Internal MedicineEndocrinologyMetabolismDiabetes
2004English

CMV Pneumonia in Allogeneic BMT Recipients Undergoing Early Treatment or Pre-Emptive Ganciclovir Therapy

Bone Marrow Transplantation
TransplantationHematology
2000English

Pre-Emptive Antibiotic Therapy to Reduce Ventilator-Associated Pneumonia: “Thinking Outside the Box”

Critical Care
Critical CareIntensive Care Medicine
2016English

All-Oral DAA Therapy Against HCV in HIV/HCV-coinfected Subjects in Real-World Practice: Madrid-CoRe Findings

Hepatology
MedicineHepatology
2018English

Shareholders' Pre-Emptive Rights

Yale Law Journal
Law
1929English

Hepatic Steatosis in HIV-HCV Coinfected Patients Receiving Antiretroviral Therapy Is Associated With HCV-related Factors but Not Antiretrovirals

BMC Research Notes
BiochemistryMedicineGeneticsMolecular Biology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy